Perhaps Mits has just become spiritually exhausted from your endless litany of criticisms. He made the point that NanoLogix has only been selling "product" since sometime in 2012 rather than the earlier date you suggest. We have had it strongly suggested that the Company's revenues have been going up steadily and if those revenues are pushing up toward $1,000,000 annually but haven't quite made it I would be quite happy to wait some more time and then be informed that revenues have risen above that point.

Remember this revenue is almost entirely just for the sales of the Flatpack to what I expect is an expanding list of customers. Given the careful management and cost controls that have occurred at NanoLogix it would seem that the Company is exceeding its needs for operating revenue through sales. My guess, and it is only a guess, is that any new share sales would most likely be aimed at capital investment requirements as NanoLogix prepares to commercialize the N-Assay product. My point is that the situation seems to be one where the outlook is positive and not one under the "cloud of doom" that you typically conjure.